Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Jones, Steven P ^a   Girod, Wesley G ^a   Granger, D Neil ^a   Palazzo, Anthony J ^a   Lefer, David J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Diabetes; Ischemic heart disease; Leukocyte adhesion molecules

Indexed keywords

GLUCOSE; PADGEM PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEMODYNAMICS; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

EID: 0032835233     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.2.h763     Document Type: Article

References (36)

1. Cohen, M. P., K. Sharma, Y. Jin, E. Hud, V. Y. Wu, J. Tomaszewski, and F. N. Ziyadeh. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. J. Clin. Invest. 95: 2338-2345, 1995.
2. Entman, M. L., L. H. Michael, R. D. Rossen, W. J. Dreyer, D. C. Anderson, and C. W. Smith. Inflammation in the course of early myocardial ischemia, FASEB J. 5: 2529-2537, 1991.
3. Eppihimer, M. J., B. Wolitzky, D. C. Anderson, M. A. Labow, and D. N. Granger. Heterogeneity of expression of E-and P-selectins in vivo. Circ. Res. 79: 560-569, 1996.
4. Feuvray, D., and G. D. Lopaschuk. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc. Res. 34: 113-120, 1997.
5. Forman, M. B., R. Virmani, and D. W. Puett. Mechanisms and therapy of myocardial reperfusion injury. Circulation 5, Suppl. W: 69-78, 1990.
6. Freedman, S., and D. L. Hatchell. Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes. Exp. Eye Res. 55: 767-773, 1982.
7. Giacomelli, F., and J. Wiener. Primary myocardial disease in the diabetic mouse: an ultrastructural study. Lab. Invest. 40: 460-473, 1979.
8. Golino, P., P. R. Maroko, and T. E. Carew. The effect of acute hypercholesterolemia on myocardial infarct size and the noreflow phenomenon during coronary occlusion-reperfusion. Circulation 75: 292-298, 1987.
9. Hansen, P. R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91: 1872-1885, 1995.
10. Henninger, D. D., M. E. Gerritsen, and D. N. Granger. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. Circ. Res. 81: 274-281, 1997.
11. Hummel, K. P., M. M. Dickie, and D. L. Coleman. Diabetes, a new mutation in the mouse. Science 153: 1127-1128, 1996.
12. Junod, A., A. E. Lambert, L. Orci, R. Pictet, A. E. Gonet, and A. E. Renold. Studies of the diabetogenic action of streptozotocin. Proc. Soc. Exp. Biol. Med. 126: 201-205, 1967.
13. Kannel, W. B., and D. L. McGee. Diabetes and cardiovascular disease. The Framingham Study. JAMA 241: 2035-2038, 1979.
14. Khaidar, A., M. Marx, B. Lubec, and G. Lubec. L-Arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation 90: 479-483, 1994.
15. Kodama, H., M. Fujita, and I. Yamaguchi. Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-d6/de) mice. Diabetologia 37: 739-744, 1994.
16. Lampter, E. R., T. K. Kishimoto, R. Rothlein, E. A. Mainolfi, J. Bertrams, H. Kolb, and S. Martin. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes 41: 1668-1671, 1992.
17. Lasky, L. A. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258: 964-969, 1992.
18. Lefer, D. J., D. M. Flynn, D. C. Anderson, and A. J. Buda. Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2421-H2429, 1996.
19. Lefer, D. J., D. M. Flynn, and A. J. Buda. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H88-H98, 1996.
20. Like, A. A., R. L. Lavine, P. L. Poffenbarger, and W. L. Chick. Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am. J. Pathol. 66: 193-224, 1972.
21. Liu, Y., J. D. Thornton, M. V. Cohen, J. M. Downey, and S. W. Schaffer. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 88: 1273-1278, 1993.
22. Lucchesi, B. R. Modulation of leukocyte-mediated myocardial reperfusion injury. Anna. Rev. Physiol. 84: 400-411, 1991.
23. Mauer, M. S., M. W. Steffes, A. F. Michael, and D. M. Brown. Studies of diabetic nephropathy in animals and man. Diabetes 25: 964-969, 1976.
24. McDonagh, P. F., J. Y. Hokama, J. G. Copeland, and J. M. Reynolds. The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes 46: 1859-1867, 1997.
25. McLeod, D. S., D. J. Lefer, C. Merges, and G. A. Lutty. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am. J. Pathol. 147: 642-653, 1995.
26. Michael, L. H., M. L. Entman, C. J. Hartley, K. A. Youker, J. Zhu, S. R. Hall, H. K. Hawkins, K. Berens, and C. M. Ballantyne. Myocardial ischemia and reperfusion: a murine model. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H2147-H2154, 1995.
27. Palazzo, A. J., S. P. Jones, D. N. Granger, D. C. Anderson, and D. J. Lefer. Coronary endothelial cell P-selectin in the pathogenesis of ischemia-reperfusion injury. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H1865-H1872, 1998.
28. Paulson, D. J. The diabetic heart is more sensitive to ischemic injury. Cardiovasc. Res. 34: 104-112, 1997.
29. Rennert, G., H. Saltz-Rennert, K. Wanderman, and S. Weitzman. Size of acute myocardial infarcts in patients with diabetes mellitus. Am. J. Cardiol. 55: 1629-1630, 1995.
30. Richardson, M., S. J. Hadcock, M. DeReske, and M. I. Cybulsky. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler. Thromb. 14: 760-769, 1994.
31. Schroder, S., W. Palinski, and G. W. Schmid-Schonbein. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am. J. Pathol. 139: 81-100, 1991.
32. Streamson, S. C., W. K. Chung, S. Wu-Peng, Y. Zhang, S. M. Liu, L. Tartaglia, and R. L. Leibel. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271: 994-996, 1996.
33. Tilton, R. G., P. A. Cole, J. D. Zions, A. Daugherty, K. B. Larson, S. P. Sutera, C. Kilo, and J. R. Williamson. Increased ischemia-reperfusion injury to the heart associated with short-term, diet-induced hypercholesterolemia in rabbits. Circ. Res. 60: 551-559, 1987.
34. Weyrich, A. S., X. Y. Ma, D. J. Lefer, K. H. Albertine, and A. M. Lefer. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91: 2620-2629, 1993.
35. Wierusz-Wysocka, S., H. Wysocki, A. Wykretowicz, A. Szczepanik, and R. Klimas. Evidence of polymorphonuclear neutrophil (PMN) activation in patients with insulin-dependent diabetes mellitus. J. Leukoc. Biol. 42: 519-523, 1987.
36. Zuanetti, G., R. Latini, A. P. Maggioni, L. Santoro, and M. G. Franzosi. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J. Am. Coll. Cardiol. 22: 1788-1794, 1993.